Crossmark

A20 prevents inflammasome-dependent arthritis by inhibiting macrophage necroptosis through its ZnF7 ubiquitin-binding domain

Crossref DOI link: https://doi.org/10.1038/s41556-019-0324-3

Published Online: 2019-05-13

Published Print: 2019-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Polykratis, Apostolos https://orcid.org/0000-0001-6720-3302
Martens, Arne https://orcid.org/0000-0002-9816-2512
Eren, Remzi Onur https://orcid.org/0000-0003-2795-0156
Shirasaki, Yoshitaka https://orcid.org/0000-0002-3808-1630
Yamagishi, Mai

Yamaguchi, Yoshifumi https://orcid.org/0000-0001-7340-4557
Uemura, Sotaro

Miura, Masayuki https://orcid.org/0000-0001-7444-5705
Holzmann, Bernhard

Kollias, George https://orcid.org/0000-0003-1867-3150
Armaka, Marietta https://orcid.org/0000-0003-0985-9076
van Loo, Geert https://orcid.org/0000-0002-8427-4775
Pasparakis, Manolis https://orcid.org/0000-0002-9870-0966
License Information

Text and Data Mining valid from 2019-05-13

Version of Record valid from 2019-05-13
More Information

Article History

Received: 30 May 2018

Accepted: 29 March 2019

First Online: 13 May 2019

Competing interests

: M.P. received consulting and speaker fees from Genentech, GSK and Boehringer.